Cyclobenzaprine · CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 · Tablet, Film Coated · Oral · AvPAK
NDC 50268-0191-15 · 50 BLISTER PACK in 1 BOX / 1 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →
7 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 13% over the past year, to $0.0169 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| NuCare Pharmaceuticals, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| American Health Packaging | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Cyclobenzaprine Hydrochloride — NDC 50268-0191-15," retrieved September 3, 2026, https://drugdashboards.com/drug/50268019115.
Free to cite with attribution — see how the data is put together.